Translational Development Acquisition (TDACU) Competitors $10.43 0.00 (0.00%) As of 07/18/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock TDACU vs. ONCHU, ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, and ANSCUShould you be buying Translational Development Acquisition stock or one of its competitors? The main competitors of Translational Development Acquisition include 1RT Acquisition (ONCHU), A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), and Agriculture & Natural Solutions Acquisition (ANSCU). These companies are all part of the "trading" industry. Translational Development Acquisition vs. Its Competitors 1RT Acquisition A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition Translational Development Acquisition (NASDAQ:TDACU) and 1RT Acquisition (NASDAQ:ONCHU) are both investment offices industry companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Does the media prefer TDACU or ONCHU? In the previous week, 1RT Acquisition had 1 more articles in the media than Translational Development Acquisition. MarketBeat recorded 1 mentions for 1RT Acquisition and 0 mentions for Translational Development Acquisition. Translational Development Acquisition's average media sentiment score of 0.00 equaled 1RT Acquisition'saverage media sentiment score. Company Overall Sentiment Translational Development Acquisition Neutral 1RT Acquisition Neutral Which has higher valuation and earnings, TDACU or ONCHU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranslational Development AcquisitionN/AN/AN/AN/AN/A1RT AcquisitionN/AN/AN/AN/AN/A Is TDACU or ONCHU more profitable? Company Net Margins Return on Equity Return on Assets Translational Development AcquisitionN/A N/A N/A 1RT Acquisition N/A N/A N/A Summary1RT Acquisition beats Translational Development Acquisition on 1 of the 1 factors compared between the two stocks. Get Translational Development Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TDACU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TDACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDACU vs. The Competition Export to ExcelMetricTranslational Development AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$159.62M$12.08B$9.40BDividend YieldN/AN/A5.56%4.04%P/E RatioN/AN/A19.1519.77Price / SalesN/AN/A26.4488.88Price / CashN/AN/A18.5528.17Price / BookN/AN/A2.315.69Net IncomeN/A-$160K$997.29M$257.97M7 Day Performance0.77%-0.34%0.28%1.92%1 Month PerformanceN/A-0.32%4.56%12.82%1 Year PerformanceN/A6.94%541.99%19.22% Translational Development Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDACUTranslational Development AcquisitionN/A$10.43flatN/AN/A$0.00N/A0.00N/AONCHU1RT AcquisitionN/A$10.38+0.2%N/AN/A$0.00N/A0.002ASPCUA SPAC III AcquisitionN/A$10.22-1.4%N/AN/A$0.00N/A0.00N/APositive NewsAGBAWAGBA GroupN/A$0.09+5.7%N/A-63.1%$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$25.08+0.0%N/A+4.5%$0.00$584M0.0050AGNCOAGNC InvestmentN/A$25.36+0.2%N/A+2.1%$0.00$584M0.0050Positive NewsAGNCNAGNC InvestmentN/A$25.37+0.3%N/A-0.8%$0.00$584M0.0050Positive NewsAGNCMAGNC InvestmentN/A$24.97+0.8%N/A-0.1%$0.00$584M0.0050Positive NewsAGNCLAGNC InvestmentN/A$24.75+0.3%N/A+2.8%$0.00$584M0.0050ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.20flatN/AN/A$0.00N/A0.00N/APositive NewsGap UpANSCUAgriculture & Natural Solutions AcquisitionN/A$10.89+1.1%N/A+6.0%$0.00N/A0.00N/APositive News Related Companies and Tools Related Companies ONCHU Competitors ASPCU Competitors AGBAW Competitors AGNCP Competitors AGNCO Competitors AGNCN Competitors AGNCM Competitors AGNCL Competitors ANSCW Competitors ANSCU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TDACU) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
